MALACRIDA, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 2.957
EU - Europa 2.097
AS - Asia 1.378
SA - Sud America 180
AF - Africa 35
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.656
Nazione #
US - Stati Uniti d'America 2.906
SG - Singapore 591
IT - Italia 531
DE - Germania 447
RU - Federazione Russa 393
HK - Hong Kong 265
CN - Cina 248
SE - Svezia 173
BR - Brasile 169
IE - Irlanda 128
AT - Austria 89
ID - Indonesia 82
GB - Regno Unito 73
FR - Francia 57
UA - Ucraina 47
CA - Canada 43
DK - Danimarca 43
IN - India 43
FI - Finlandia 39
KR - Corea 36
NL - Olanda 21
JP - Giappone 20
VN - Vietnam 20
BE - Belgio 17
TW - Taiwan 12
TR - Turchia 11
ZA - Sudafrica 9
EG - Egitto 8
BD - Bangladesh 7
MX - Messico 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
SA - Arabia Saudita 6
AU - Australia 5
MY - Malesia 5
PK - Pakistan 5
PL - Polonia 5
ES - Italia 4
EU - Europa 4
GR - Grecia 4
MA - Marocco 4
RO - Romania 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
IQ - Iraq 3
PH - Filippine 3
AM - Armenia 2
AO - Angola 2
AR - Argentina 2
CL - Cile 2
HU - Ungheria 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
LY - Libia 2
NG - Nigeria 2
RS - Serbia 2
AZ - Azerbaigian 1
BH - Bahrain 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 6.656
Città #
Ann Arbor 1.167
Singapore 400
Frankfurt am Main 346
Hong Kong 262
Wilmington 197
Milan 188
Chandler 154
Fairfield 128
Dublin 126
Ashburn 97
Santa Clara 91
Vienna 81
Woodbridge 78
Dearborn 67
New York 67
Jakarta 64
Boardman 60
Princeton 54
Houston 48
Beijing 46
Shanghai 41
Cambridge 37
Moscow 35
Jacksonville 34
Seattle 33
Nanjing 23
Los Angeles 22
Pune 22
Munich 21
Appiano Gentile 19
Chicago 19
Hefei 19
Seoul 19
Rome 17
Brussels 16
Lawrence 16
Nuremberg 16
Helsinki 15
London 15
San Diego 14
Council Bluffs 13
Florence 12
Altamura 11
Melzo 11
Nanchang 11
São Paulo 11
Turku 11
Desio 10
Fremont 10
Hangzhou 10
Pavia 10
Andover 8
Brasília 8
Como 8
Düsseldorf 8
Lappeenranta 8
Tianjin 8
Edmonton 7
Romola 7
Shenyang 7
Belo Horizonte 6
Brooklyn 6
Buffalo 6
Dallas 6
Jinan 6
Kunming 6
Mountain View 6
Ottawa 6
Rio de Janeiro 6
Tokyo 6
Yogyakarta 6
Bergamo 5
Cagliari 5
Chennai 5
Guelph 5
Lanoraie 5
Mainz 5
Ningbo 5
Toronto 5
Assago 4
Boston 4
Cairo 4
Dong Ket 4
Fortaleza 4
Fukuoka 4
Giwangan 4
Guadalajara 4
Guangzhou 4
Hebei 4
Jiaxing 4
Kaohsiung City 4
Kiev 4
Lachine 4
Lauterbourg 4
Montreal 4
Quito 4
Seregno 4
Sesto San Giovanni 4
Shah Alam 4
Torre a Mare 4
Totale 4.553
Nome #
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 330
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 318
EVALUATION OF ANTITUMORAL EFFECTS OF HIBISCUS SABDARIFFA ON MULTIPLE MYELOMA CELLS 297
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 277
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 274
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 266
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 263
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 244
Are sigma receptor modulators a weapon against multiple sclerosis disease? 234
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 233
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 224
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 216
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 215
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 197
Evaluation of in vitro antitumoral activity and neurotoxicity of a Hibiscus Sabdariffa ethyl acetate fraction against human multiple myeloma cells 182
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 181
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 175
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 158
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 155
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 148
Antitumoral effects of Hibiscus Sabdarifa on human oral squamous cell carcinoma and multiple myeloma cells 147
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 146
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 144
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 142
Rigosertib and cholangiocarcinoma: A cell cycle affair 127
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 124
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 123
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells 116
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent 114
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 112
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 112
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 109
In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells 100
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 97
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 94
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells 82
The Role of NMNAT2/SARM1 in Neuropathy Development 79
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 75
RICOLINOSTAT INDUCES MICROTUBULE ACETYLATION AND NEURITE REGENERATION IN CELLULAR MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHY 75
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 72
Neurodegeneration: can metabolites from Eremurus persicus help? 66
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 64
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES 60
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 56
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa—part 2 55
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 54
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 49
Totale 7.181
Categoria #
all - tutte 27.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 0 10
2020/20211.175 24 41 115 140 101 118 135 130 102 69 92 108
2021/2022643 63 92 77 53 42 56 30 30 20 25 50 105
2022/20231.012 94 221 158 88 80 121 31 63 55 21 52 28
2023/2024668 24 23 31 23 65 138 91 37 48 21 7 160
2024/20252.514 183 175 189 134 263 180 188 90 296 362 238 216
Totale 7.181